Abstract:Histone H3 lysine-9 (H3K9) methylation is essential for retinoblastoma protein (RB)-mediated heterochromatin formation, epigenetic silencing of S-phase genes and permanent cell cycle arrest or cellular senescence. Besides as an H3K4 demethylase, lysine-specific demethylase-1 (LSD1) has been shown to promote H3K9 demethylation. However, it is unexplored whether LSD1 has a causal role in regulating cell cycle entry and senescence. Here we demonstrate that genetic depletion or pharmacological inhibition of LSD1 triggers G1 arrest and cellular senescence. Genome-wide chromatin immunoprecipitation-sequencing analysis reveals that LSD1 binding sites overlap significantly with those bound by the S-phase gene transcription factor E2F1. Gene ontology analysis demonstrates that a large portion of E2F1 and LSD1 cotargeted genes are involved in cell cycle and proliferation. Further analyses show that depletion of LSD1 increases the level of H3K9me2 and thereby represses expression of the LSD1-E2F1 cotarget genes, but has no effects on H3K4me2 level in those loci. In contrast, knockdown of the H3K4me2 reader PHF8 decreases the H3K4me2 level at the LSD1-E2F1 cotargeted loci, but this effect is rescued by codepletion of LSD1. Furthermore, the enzymatic activity of LSD1 is essential for H3K9me2 demethylation at cell cycle gene loci. Notably, cotreatment of chemotherapeutic agent camptothecin enhanced LSD1 inhibitor-induced senescence and growth inhibition of cancer cells in vitro and in mice. Our data reveal LSD1 as a molecular rheostat selectively regulating H3K9 demethylation at cell cycle gene loci, thereby representing a key player in oncogenesis and a viable target for cancer therapy.

Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition

Opposing LSD1 Complexes Function in Developmental Gene Activation and Repression Programmes

The scaffolding function of LSD1 controls DNA methylation in mouse ESCs

Regulation of LSD1 histone demethylase activity by its associated factors.

Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.

Histone H3 Lysine 4 Monomethylation Modulates Long-Range Chromatin Interactions at Enhancers

Short Article Regulation of LSD1 Histone Demethylase Activity by Its Associated Factors

LSD1 Coordinates with the SIN3A/HDAC Complex and Maintains Sensitivity to Chemotherapy in Breast Cancer.

LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16.

A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation.

LSD1 Knockdown Reveals Novel Histone Lysine Methylation in Human Breast Cancer MCF-7 Cells

LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation

Targeting LSD1 in cancer: Molecular elucidation and recent advances

Cooperative role of LSD1 and CHD7 in regulating differentiation of mouse embryonic stem cells

LSD1n is an H4K20 Demethylase Regulating Memory Formation Via Transcriptional Elongation Control

Histone demethylase LSD1 is required to induce skeletal muscle differentiation by regulating myogenic factors

An autoinhibitory switch of the LSD1 disordered region controls enhancer silencing

LSD1 is required for euchromatic origin firing and replication timing

LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer

Histone Demethylase Lsd1 Represses Hematopoietic Stem and Progenitor Cell Signatures During Blood Cell Maturation